Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Shenghuo Reports Flat Revenues

publication date: Apr 8, 2008

China Shenghuo Pharmaceutical Holdings, Inc. released its 2007 financial statement last week, reporting that its net earnings were $4 million on sales of $20 million. The revenue figure was virtually identical with the 2006 number, though earnings were up from $3.5 million. However, the report was lower than expected because earlier this year, as it announced its first-half results, China Shenghuo said it expected revenues to hit $25 million for full-year 2007. More details...

Stock Symbol: (AMEX: KUN)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here